DRG Market Assessment 보고서
질환 개요 및 예측, 역학 인텔리전스, 바이오시밀러 인텔리전스, China In-depth 등 폭넓은 시장 인텔리전스를 확인해 보세요.
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia | Emerging Therapies | Venclexta (venetoclax) | US | Wave 1 | 2016
LaunchTrends: Venclexta (Wave 1) is the first in a series of syndicated reports designed to track physician perception, uptake, and competitive environment regarding the newly launched chronic…
Methicillin-Resistant Staphylococcus Aureus Infections (MRSA) | Current Treatment | US | 2016
Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important gram-positive pathogen in both the hospital and outpatient treatment settings. The recent FDA approvals of tedizolid (…